Matches in Wikidata for { <http://www.wikidata.org/entity/Q50215070> ?p ?o ?g. }
- Q50215070 description "2018 nî lūn-bûn" @default.
- Q50215070 description "2018 թվականի փետրվարի 2-ին հրատարակված գիտական հոդված" @default.
- Q50215070 description "2018年の論文" @default.
- Q50215070 description "2018年学术文章" @default.
- Q50215070 description "2018年学术文章" @default.
- Q50215070 description "2018年学术文章" @default.
- Q50215070 description "2018年学术文章" @default.
- Q50215070 description "2018年学术文章" @default.
- Q50215070 description "2018年学术文章" @default.
- Q50215070 description "2018年學術文章" @default.
- Q50215070 description "2018年學術文章" @default.
- Q50215070 description "2018年學術文章" @default.
- Q50215070 description "2018年學術文章" @default.
- Q50215070 description "2018年學術文章" @default.
- Q50215070 description "2018년 논문" @default.
- Q50215070 description "article científic" @default.
- Q50215070 description "article scientific" @default.
- Q50215070 description "article scientifique" @default.
- Q50215070 description "articol științific" @default.
- Q50215070 description "articolo scientifico" @default.
- Q50215070 description "artigo científico" @default.
- Q50215070 description "artigo científico" @default.
- Q50215070 description "artigo científico" @default.
- Q50215070 description "artikel ilmiah" @default.
- Q50215070 description "artikull shkencor" @default.
- Q50215070 description "artikulong pang-agham" @default.
- Q50215070 description "artykuł naukowy" @default.
- Q50215070 description "artículo científico publicado en 2018" @default.
- Q50215070 description "artículu científicu" @default.
- Q50215070 description "bilimsel makale" @default.
- Q50215070 description "bài báo khoa học" @default.
- Q50215070 description "naučni članak" @default.
- Q50215070 description "scienca artikolo" @default.
- Q50215070 description "scientific article published on 2 February 2018" @default.
- Q50215070 description "scientific article published on 2 February 2018" @default.
- Q50215070 description "scientific article published on 2 February 2018" @default.
- Q50215070 description "teaduslik artikkel" @default.
- Q50215070 description "tieteellinen artikkeli" @default.
- Q50215070 description "tudományos cikk" @default.
- Q50215070 description "vedecký článok" @default.
- Q50215070 description "vetenskaplig artikel" @default.
- Q50215070 description "videnskabelig artikel" @default.
- Q50215070 description "vitenskapelig artikkel" @default.
- Q50215070 description "vitskapeleg artikkel" @default.
- Q50215070 description "vědecký článek" @default.
- Q50215070 description "wetenschappelijk artikel" @default.
- Q50215070 description "wissenschaftlicher Artikel" @default.
- Q50215070 description "επιστημονικό άρθρο" @default.
- Q50215070 description "мақолаи илмӣ" @default.
- Q50215070 description "наукова стаття, опублікована в лютому 2018" @default.
- Q50215070 description "научна статия" @default.
- Q50215070 description "научная статья" @default.
- Q50215070 description "научни чланак" @default.
- Q50215070 description "научни чланак" @default.
- Q50215070 description "מאמר מדעי" @default.
- Q50215070 description "مقالة علمية نشرت في 2 فبراير 2018" @default.
- Q50215070 description "২ ফেব্রুয়ারি ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q50215070 description "บทความทางวิทยาศาสตร์" @default.
- Q50215070 description "სამეცნიერო სტატია" @default.
- Q50215070 name "A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia." @default.
- Q50215070 name "A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia." @default.
- Q50215070 type Item @default.
- Q50215070 label "A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia." @default.
- Q50215070 label "A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia." @default.
- Q50215070 prefLabel "A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia." @default.
- Q50215070 prefLabel "A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia." @default.
- Q50215070 P1433 Q50215070-69326A1D-5303-4441-A95D-1E822DA7DB19 @default.
- Q50215070 P1476 Q50215070-EC0D1B60-EBFE-49AF-B800-9AF7B8AE67E3 @default.
- Q50215070 P2093 Q50215070-04281513-192E-4E8F-B340-1D9E2477132A @default.
- Q50215070 P2093 Q50215070-045E6579-B21D-45B7-92EA-B30574162471 @default.
- Q50215070 P2093 Q50215070-0A170ADE-AFB1-408F-BF64-F1484CD16149 @default.
- Q50215070 P2093 Q50215070-1AEE86C3-B6B8-4284-84DF-824A009E8466 @default.
- Q50215070 P2093 Q50215070-27EA7603-EFCD-4383-B64D-EF46EA133C9F @default.
- Q50215070 P2093 Q50215070-31B387EF-020E-4EA4-9747-99677BF232A8 @default.
- Q50215070 P2093 Q50215070-377BCA0C-D55E-44E5-97DA-CF5E20A6C950 @default.
- Q50215070 P2093 Q50215070-5A363B3C-CD42-41FD-8549-B63376812375 @default.
- Q50215070 P2093 Q50215070-8A13A034-5676-4BEC-816E-2109152115D7 @default.
- Q50215070 P2093 Q50215070-8F1C8FBD-B648-4025-999C-15797318D2D1 @default.
- Q50215070 P2093 Q50215070-9855A8AE-1160-4999-86EE-85BA57E66FCF @default.
- Q50215070 P2093 Q50215070-9A798264-4EFC-4FF1-9F7B-45DF833E8C3A @default.
- Q50215070 P2093 Q50215070-9AF8984D-F2A0-424C-8805-4F55B48B27AE @default.
- Q50215070 P2093 Q50215070-A505418C-148B-491F-95CD-99ADE5BC20BC @default.
- Q50215070 P2093 Q50215070-AC16B829-8D39-4879-8288-98FC7053ED35 @default.
- Q50215070 P2093 Q50215070-AE105256-03FC-4E43-BB4C-13524B4483BD @default.
- Q50215070 P2093 Q50215070-B65ACA2C-7526-4CDE-BB90-1E37F914F05F @default.
- Q50215070 P2093 Q50215070-B832E989-BAD3-425F-A78F-074D1C9BE7EB @default.
- Q50215070 P2093 Q50215070-BBA542A4-5250-4843-8C86-7EDA4AC2D22A @default.
- Q50215070 P2093 Q50215070-D36E07A3-0D74-41B5-B8EF-44817DC162DA @default.
- Q50215070 P304 Q50215070-7F664D1A-A342-4879-9D97-8A077113054C @default.
- Q50215070 P31 Q50215070-80809612-A3C7-42F4-B7FA-B76ABECB6BC3 @default.
- Q50215070 P356 Q50215070-FD3F9FFD-1052-4916-B3DF-456B14B1C838 @default.
- Q50215070 P433 Q50215070-9DB94904-412A-4CB4-B556-65C2ECEAEB45 @default.
- Q50215070 P478 Q50215070-D6D51A4E-3000-4940-A6D2-66F756DCE616 @default.
- Q50215070 P50 Q50215070-435C726A-BEAD-488A-B12E-119B5CDAAC33 @default.
- Q50215070 P50 Q50215070-A761B9F2-0BB9-493E-81B6-D6DD99762600 @default.
- Q50215070 P577 Q50215070-072CFD6A-01BC-404F-8C5D-F7FFDBF78EAC @default.
- Q50215070 P698 Q50215070-77FFD444-F8EB-4286-810C-FBD948E00A5C @default.
- Q50215070 P921 Q50215070-E0AEA6E5-3C69-4283-95C1-08A5332445F6 @default.
- Q50215070 P356 S00277-018-3229-5 @default.
- Q50215070 P698 29392425 @default.